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Abstract
Background: The function of T helper cell subsets in vivo depends on their location, and one hallmark of T cell
differentiation is the sequential regulation of migration-inducing chemokine receptor expression. CC-chemokine receptor 6
(CCR6) is a trait of tissue-homing effector T cells and has recently been described as a receptor on T helper type 17 (Th17)
cells. Th17 cells are associated with autoimmunity and the defence against certain infections. Although, the polarization of
Th cells into Th17 cells has been studied extensively in vitro, the development of those cells during the physiological
immune response is still elusive.
Methodology/Principal Findings: We analysed the development and functionality of Th17 cells in immune-competent
mice during an ongoing immune response. In naı ¨ve and vaccinated animals CCR6
+ Th cells produce IL-17. The robust
homeostatic proliferation and the presence of activation markers on CCR6
+ Th cells indicate their activated status.
Vaccination induces antigen-specific CCR6
+ Th17 cells that respond to in vitro re-stimulation with cytokine production and
proliferation. Furthermore, depletion of CCR6
+ Th cells from donor leukocytes prevents recipients from severe disease in
experimental autoimmune encephalomyelitis, a model for multiple sclerosis in mice.
Conclusions/Significance:Inconclusion,wedefinedCCR6 asaspecificmarkerforfunctional antigen-specificTh17 cellsduring
the immune response. Since IL-17 production reaches the highest levels during the immediate early phase of the immune
response and the activation of Th17 cells precedes the Th1 cell differentiation we tent to speculate that this particular Th cell
subsetmayrepresent a first line effector Thcell subpopulation. Interferencewiththe activationof this Thcell subtype provides
an interesting strategy to prevent autoimmunity as well as to establish protective immunity against infections.
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Introduction
In the late 80ies Mossman et al. designated Th1 and Th2 cells
according to their capacity to secrete the cytokines IFN-c and IL-
4, respectively [1]. Since then, IL-10 and TGF-b producing T cells
were identified as regulatory T cells [2]. The increasing knowledge
about the heterogeneity of the Th cell subpopulations helped to
explain how most infections are resolved. Nevertheless, the
involvement of Th cells in the elimination of extracellular bacteria
and fungi, and in the development of autoimmune disorders could
not be adequately explained with the T effector cell subpopula-
tions as defined in the literature so far. Recent studies on the role
of the APC-derived cytokine IL-23 for the development of
autoimmunity and clearance of infections [3–6] expanded our
knowledge in T cell immunology by pointing to a new Th cell
subtype involved in these mechanisms. These particular Th cells
are characterised by the production of the cytokine IL-17 and are
now referred to as Th17 cells [7,8]. While the expansion and
maintenance of Th17 cells depends on IL-23 [9], their generation
in mice is induced by the early inflammatory cytokines IL-21, IL-
6, and TGF-b [9–11]. These cytokines are produced early in the
inflammatory process by innate effector cells and Th cells [12,13].
Once the Th cells are differentiated, the cytokine milieu influences
the functionality of each of the Th cell subsets; Thl, Th2, and
Th17 cells produce cross-regulatory cytokines that are mutually
inhibitory for the respective other subsets [8,14]. Nevertheless, it is
still unclear how the development and maintenance of Th17 cells
is regulated during the immune response in vivo. One of the
reasons for this is the lack of well-characterised surface markers
identifying Th17 cells. Based on the findings that Th17 cells
express CCR6 [15,16] we examined the generation of IL-17
producing Th cells in a non-infectious vaccination model with
ovalbumin (OVA), and analysed the functionality of Th17 cells
during the immune response in immune-competent C57BL/6
mice. For the first time, we demonstrated that CCR6 is a selective
marker for the identification of Th17 cells during an immune
response. Furthermore, CCR6
+ Th17 cells were present even in
naı ¨ve mice and this population showed signs of activation in the
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proportion of IL-17 producing Th cells in the lymph nodes
decreased compared to the Th1 cell subpopulation. Nevertheless,
antigen-specific IL-17 producing responder cells arose in the
lymph node. The functionality of CCR6
+ Th17 cells was
demonstrated in adoptively transferred experimental autoimmune
encephalomyelitis (at-EAE); transfer of lymph node cells contain-
ing CCR6
+ Th17 cells led to severe disease while depletion of
CCR6
+ Th cells attenuated the course of at-EAE.
Materials and Methods
Mice
Inbred C57BL/6 mice were purchased from Charles River
(Sulzfeld, Germany), inbred SJL/J mice were obtained from
Harlan Winkelmann (Borchen, Germany). OVA TCR transgenic
(OT-II) mice were bred and maintained in the animal facilities of
the University of Regensburg. Mice of 8–16 weeks of age were
used. Vaccination with OVA was performed injecting 100 mg
OVA and 8 nmol CpG-ODN 1668 [17] s.c. into the hind footpad.
All experiments were conducted according to animal experimental
ethics committee guidelines and were approved by the local
authorities.
Antibodies and reagents
The following antibodies were used for flow cytometry: Rat
anti-mouse CD4 (clone RM4-5), rat anti-mouse CD8a (clone 53-
6.7), rat anti-mouse CD44 (clone IM7), rat anti-mouse CD62L
(clone MEL-14), hamster anti-mouse CD69 (clone H1.2F3), rat
anti-mouse IFN-c (clone XMG1.2), rat anti-mouse IL-17 (clone
TC11-18H10.1), mouse anti-BrdU (clone B44), PE and APC
labelled isotype control IgG. All mAb and isotype controls were
purchased from BD Biosciences (Heidelberg, Germany). Rat anti-
mouse CCR6 (clone 140706) was purchased from R&D Systems
(Wiesbaden, Germany). Hamster anti-mouse CD3e (clone
145.2C11) was purified from hybridoma cell culture supernatant
using protein-G-sepharose columns (GE Healthcare, Mu ¨nchen,
Germany).
Flow cytometry and cell sorting
Popliteal and inguinal lymph nodes were harvested. Single cell
suspension was prepared as previously described [18]. Cells were
incubated with the appropriate antibodies in staining buffer (PBS
containing 2% FCS). Data was collected on the LSR II flow
cytometer (BD Biosciences) and analysed using the DIVA software
(BD Biosciences). All staining profiles were based on live-gated
cells, as determined by forward and sideward scatter properties.
For the separation of CD4
+ T cells the MACS system (Miltenyi
Biotec, Bergisch Gladbach, Germany) was employed using anti-
mouse CD4 MACS beads. For further separation of CD4
+
CCR6
+ lymphocytes 5610
7 cells per sample were incubated in
500 ml of staining buffer with the appropriate antibodies. Cells
were sorted on the FACSAria cell sorter (BD Biosciences).
Analysis of cell proliferation in vitro
Lymph node cells (5610
5) were labelled with CFSE (Invitrogen,
Karlsruhe, Germany) at a final concentration of 1.25 mM, and
cultured in 200 ml RPMI 1640 (PAN Biotech, Aidenbach,
Germany) supplemented with 10% FCS (Sigma-Aldrich,
Mu ¨nchen, Germany), 50 mM b-mercaptoethanol, 2 mM L-
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin
(PAN Biotech). Cells were stimulated with OVA (20 mg/ml;
Sigma-Aldrich) or plate bound anti-CD3 (5 mg/ml) and prolifer-
ation was assessed by flow cytometry.
Measurement of cell proliferation in vivo
OT-II mice were immunised for the indicated periods of time
and fed with 5-Bromo-29-deoxyuridine (BrdU; 800 mg/ml) in
drinking water for three days. Draining lymph nodes were
harvested and single cell suspensions were prepared. Cell surface
staining was performed. The detection of the incorporated BrdU
was conducted with the BrdU Flow Kit (BD Biosciences)
according to the manufacturer’s instructions with the exception
that a FITC-conjugated mouse anti-BrdU (clone B44) was used for
detection of the thymidine analogue. Proliferation of either CD4
+
CCR6
+ or CD4
+ CCR6
2 cells was assessed by the presence of
BrdU fluorescence in dividing cells.
Determination of cytokine production
Cells were stimulated with plate bound anti-CD3 (5 mg/ml) or
OVA (20 mg/ml) in vitro and supernatants were collected. IFN-c
and IL-17A protein quantification was performed with DUO-
ELISA kits (R&D Systems) following the manufacturer’s instruc-
tions. The detection limit for IFN-c and for IL-17A was 20 pg/ml.
Intracellular cytokine staining
Freshly isolated or in vitro reactivated lymph node cells were
stimulated with ionomycin (1 mM; Sigma-Aldrich), and PMA
(80 ng/ml; Sigma-Aldrich) in the presence of GolgiStop (BD
Biosciences) for 4 h. Intracellular staining was performed using the
Cytofix/Cytoperm Kit (BD Biosciences) according to the manu-
facturer’s instructions.
Induction and assessment of at-EAE
SJL/J mice were immunised by injection of 200 mg of murine
PLP (aa139–151, Pepceuticals Limited, UK), emulsified in
Complete Freund’s adjuvant (CFA) (Difco Laboratories, Detroit,
Michigan, USA) supplemented with 500 mg Mycobacterium
tuberculosis (Difco Laboratories). After 10 days cells were harvested
from draining lymph nodes and single cell suspensionwas prepared.
Lymphocytes were sorted into CD4
2, CD4
+ CCR6
2 and CD4
+
CCR6
+ fractions. After the sorting procedure cell fractions either
including or excluding CD4
+ CCR6
+ cells were combined in the
same ratio as present in the starting lymph nodes and cultured with
5 mg/ml PLPfor 72 h.Afterwards, lymphnode cellswereharvested
and washed twice with PBS. Each recipient mouse received
3.5610
6 activated lymph node cells by i.p. injection. Weight and
clinical score were recorded at the indicated time points according
to the following criteria: 0=healthy; 1=limp tail; 2=partial
hindlimb weakness and/or ataxia; 3=complete paralysis of at least
one hindlimb; 4=severe forelimb weakness; 5=moribund or dead.
Statistical analysis
Error bars represent SEM. For statistical analysis two-tailed
Student’s t test was used unless indicated otherwise; p,0.05 was
considered significant. For at-EAE experiments differences were
analyzed by the non-parametric Mann-Whitney U test; p,0.05
was considered significant.
Results
Analysis of CCR6
+ Th cells in immune-competent C57BL/
6 mice
Antigen-specific T cell response occurs in distinct steps. After
activation Th cells differentiate into effector cells that migrate to
their target organs, and orchestrate the immune response.
Therefore, re-organization of adhesion molecules and chemokine
receptors is a hallmark of T cell differentiation [19].
In Vivo Analysis of Th17 Cells
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+
Th cells in naı ¨ve and vaccinated mice. Analysis of the cytokine
pattern of lymph node residing CCR6
+ Th cell fraction in naı ¨ve
mice showed that this T cell subpopulation clearly consists of Th17
cells; 16.1% (64.7) of the CD4
+ CCR6
+ Th cell fraction produced
IL-17 (Fig. 1A, left panel). In the respective Th cell fraction nearly
no IFN-c production was observed (0.6%60.3; Fig. 1A, left panel).
In addition, neither IL-4 nor the anti-inflammatory cytokine IL-10
were detectable in CCR6
+ Th cells (data not shown). Th cells that
were negative for CCR6 did not produce IL-17 (Fig. 1A, right
panel). The exclusive production of the cytokine IL-17 allowed us
to follow the generation of Th17 cells according to the surface
marker CCR6 during the immune response in our study.
Since the CCR6
+ IL-17 producing cells were present in naı ¨ve
mice we were interested in the phenotype of those cells. CCR6
+
Th cells expressed the activation markers CD69 and CD44
(Fig. 1B) in untreated mice. In contrast to the former markers,
CD62L and CD45RB are characteristics of naı ¨ve Th cells and
were down regulated on CCR6
+ Th cells (Fig. 1B). The expression
pattern of the activation markers and adhesion molecules on
CCR6
+ Th cells pointed to an activated phenotype of these cells in
naı ¨ve mice; it did not change substantially after immunisation
(data not shown). To correlate the activated phenotype with
functional properties on CCR6
+ Th cells we determined in vivo
proliferation of those cells in non-vaccinated C57BL/6 mice. In
naı ¨ve mice the CCR6
+ Th cell subpopulation proliferated
vigorously. 15.5% (65.2; Fig. 1C) of the CCR6
+ Th cells
incorporated BrdU within the treatment period of three days.
Nearly no proliferation was detected in CCR6
2 Th cells (0.4%
cells in proliferation60.2; Fig. 1C).
Vaccination favours the development of IFN-c producing
Th1 cells
To clarify the role of CCR6
+ Th17 cells during the immune
response we vaccinated C57BL/6 mice with OVA and CpG-
oligodeoxynucleotides (ODN) as adjuvant. These conditions
mimic the situation during infections with pathogens. During the
acute phase of the T cell response on day six after vaccination
lymph node cells had a reduced capacity to produce IL-17 protein
after polyclonal activation (Fig. 2A left panel). As in naı ¨ve animals
IL-17 production was restricted to the CCR6
+ Th cell subpop-
ulation after immunisation (Fig. 2B, left panel). Following
immunisation IFN-c became the dominant cytokine produced
by lymph node cells (Fig. 2A, right panel). Thereby, IFN-c was
synthesised by CCR6
2 Th cells (Fig. 2B, right panel) and cytotoxic
T lymphocytes (CTL; data not shown). To rule out whether these
findings are due to the use of CpG-ODN we performed additional
immunisation experiments using alum and IFA as adjuvants. Both
alum precipitated OVA and OVA emulsified in IFA induced the
same reduction in Th17 cells during the peak phase of the immune
response as seen in CpG-OVA vaccinated mice (Fig. S1). The
decrease in IL-17 producing Th cells after vaccination correlated
Figure 1. Residual CD4
+ CCR6
+ T cells show an activated
phenotype in C57BL/6 mice. (A and B) Lymph nodes of naı ¨ve C57BL/
6 mice were harvested and cells were analysed by multicolour flow
cytometry. For each experiment lymph node cells from three mice were
pooled. (A) Cells were gated on CD4
+ cells and the expression of CCR6
and IL-17 or CCR6 and IFN-c was monitored. The percentage of cytokine
producing cells in the live cell gate was determined. Data is given as
mean (6SEM) of three independent experiments. (B) The expression of
activation markers on CD4
+ CCR6
+ (dark grey histogram) and CD4
+
CCR6
2 (light grey histogram) cells was analysed. Data is representative
for three independent experiments. (C) OT-II mice were fed with BrdU.
Cells were isolated from lymph nodes. In vivo proliferation of Th cells
was assessed by their BrdU-linked fluorescence. Representative density
plots of gated CD4
+CCR6
+ (left panel) and CD4
+CCR6
2 (right panel) cells
are shown. Data is given as mean (6SEM) of six independent
experiments.
doi:10.1371/journal.pone.0002951.g001
In Vivo Analysis of Th17 Cells
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+ Th cells in the lymph nodes (Fig. 2C).
To elucidate the mechanisms underlying the different kinetics of
the induction of IL-17 and IFN-c, respectively, we determined the
kinetics of the expansion of CCR6
+ and CCR6
2 cells during the
course of the immune response in vivo. Immunisation led to a
tremendous induction of proliferation of the CCR6
2 Th cell
subpopulation (Fig. 2D; 34.7%68.6). Between days three and six
of the immune reaction the expansion of CCR6
2 cells was almost
completed and the proliferation rate dropped to 5.4% of
proliferating cells (62.1). As CCR6
+ Th cells showed a high
proliferation rate in naı ¨ve mice (Fig. 1C and 2D), the
responsiveness of CCR6
+ Th cells to vaccination was rather weak
but clearly detectable (Fig. 2D; 33.6%68.4).
Antigen-specific CCR6
+ Th17 cells are generated in
response to OVA in C57BL/6 mice
So far we noticed proliferation of CCR6
+ Th cells following
immunisation with OVA and CpG-ODN but the antigen-specificity
of these vaccination-induced cells still needed to be clarified.
Therefore, we tested whether in vivo activated Th cells are capable
Figure 2. Production of IL-17 and IFN-c is differentially regulated during the immune response. (A–C) C57BL/6 mice were immunised for
the indicated periods of time. For each experiment lymph node cells from three mice were pooled. (A) Cells were cultured in the presence of plate
bound anti-CD3. After 72 h in culture supernatants were collected. The amounts of IL-17 (left panel) and IFN-c (right panel) were analysed by ELISA.
ELISA was performed in duplicates. Data is given as mean (6SEM) of two independent experiments, * p,0.05. (B) Intracellular cytokine staining was
performed immediately after isolation as described in materials and methods. The percentage of IL-17 and IFN-c producing cells (6SEM) within the
CD4
+ T cell fraction was determined by flow cytometry. Three independent experiments were performed. (C) CD4
+ lymphocytes were analysed for
the expression of CCR6. Mean values (6SEM) of three independent experiments are shown, * p,0.05. (D) OT-II mice were immunised for the
indicated periods of time. In vivo proliferation of CD4
+ CCR6
+ (open bars) and CD4
+ CCR6
2 (black bars) cells was determined according to their BrdU-
linked fluorescence. Data is given as mean values (6SEM) of three (day 6) to six (day 0 and d 3) independent experiments. * p,0.01.
doi:10.1371/journal.pone.0002951.g002
In Vivo Analysis of Th17 Cells
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antigen. Cells obtained either from naı ¨ve mice or mice that were
immunised for two days did not release IL-17 in response to OVA-
challenge. On day six after immunisation cellsproduced considerable
amounts of IL-17 (Fig. 3A, left panel). In accordance to polyclonal
activation antigen-specific re-stimulation resulted in a strong
induction of IFN-c release (Fig. 3A, right panel).
We next determined the capacity of in vivo activated CCR6
+
Th17 cells to expand in vitro. On day six after vaccination we
detected antigen-induced proliferation of the CCR6
+ Th cell subset
(Fig. 3B, right panel). Cells cultured without exogenous antigen also
progressed in divisions (Fig. 3B, left panel). This suggests that
endogenous antigen derived from the previous vaccination induced
proliferation in those cells. This hypothesis was supported by the
fact that T cells obtained from mice on day 21 after immunisation
did not proliferate without re-stimulation but responded to the
administration of OVA (Fig. 4A). Moreover, at that late point of the
immune response antigen-specific reactivity was largely limited to
the CCR6
+ Th cell subpopulation. Whereas CCR6
+ and CCR6
2
Th cells proliferated to the same extent upon polyclonal stimulation
only a small proportion of the CCR6
2 Th cell subpopulation
showed responsiveness to in vitro challenge with antigen (Fig. 4B).
CCR6 defines functional antigen-specific Th17 cells that
induce autoimmune disease
To investigate whether CCR6 could be used as a specific
marker to isolate functional Th17 cells we induced EAE in mice.
In this murine model for multiple sclerosis the autoimmune
deterioration of the central nervous system (CNS) is mainly
mediated by inflammatory Th17 cells [20]. Antigen-specific Th
cells are primed by vaccination with the myelin-specific antigen
PLP. Disease is induced transferring in vivo activated lymph node
cells into naı ¨ve recipient mice. Therefore, depletion of CCR6
+ Th
cells in that particular transfer model should prevent disease
development in mice. In accordance with our previous observa-
tions we observed a significant reduction of IL-17 production in
PLP re-stimulated lymph node cells depleted of CCR6
+ Th cells
(Fig. 5A). Analysis of sorted CCR6
+ and CCR6
2 Th cell fractions
revealed that IL-17 was exclusively produced by CCR6
+ Th cells
(Fig. 5B). Although, lymph node cells that were depleted for
CD4
+CCR6
+ cells regained CCR6 expression (Fig. S2A) nearly no
IL-17 production was detected in those cells after in vitro re-
stimulation for 3 days (Fig. S2B). Consequently, adoptive transfer
of lymph node cells containing CCR6
+ Th cells into naı ¨ve
recipients induced severe EAE whereas depletion of CCR6
+ Th
cells form donor cells considerably attenuated the severity of
disease in recipient mice, and reduced their mortality (Fig. 5C and
Table 1).
Discussion
Differential expression of chemokine receptors is an accepted
principle for the classification of different Th cell subpopulations
[21,22]. The chemokine receptor CCR6 is expressed on activated
Figure 3. Induction of antigen-specific CCR6
+ Th17 cells after vaccination. C57BL/6 mice were immunised for the indicated periods of time.
Lymph node cells were isolated and stimulated in vitro. (A) OVA-stimulated (black bars) or control cells (open bars) were cultured for 72 h in vitro. The
amounts of IL-17 and IFN-c were quantified. ELISA was performed in duplicates. Mean values (6SEM) of three independent experiments are depicted
(n.d. indicates values below the detection limit). (B) Lymph node cells of three mice were pooled, labelled with CFSE and cultured for 96 h.
Proliferation of OVA-stimulated (right panel) and control CD4
+ CCR6
+ cells (left panel) was determined by CFSE dilution. Each data point represents
one experiment (n=3/time point). Horizontal bars indicate the mean. * p,0.05.
doi:10.1371/journal.pone.0002951.g003
In Vivo Analysis of Th17 Cells
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+ Th cells has been rather
obscure for a long time [23]. Recent reports on Th17 cells start to
enlighten the role of this particular T cell subset [15]. In our study
we demonstrated for the first time that CCR6 is a valid marker to
define functional antigen-specific Th17 cells in mice. In naı ¨ve and
immunised mice IL-17 producing Th cells from lymph nodes
exclusively resided within the CCR6
+ Th cell fraction. Analysis of
the cytokine production of sorted CCR6
+ Th cells clearly showed
that this Th cell fraction was the only source of IL-17 protein
within the Th cell population.
A common issue linking CCR6 expressing Th cells and Th17
cells is their association with autoimmune diseases [24–26]. IL-17
producing Th cells have been shown to be responsible for the
development of EAE in mice [20]. As a matter of fact depletion of
auto-reactive Th17 cells on the basis of CCR6 expression from
lymph node cells attenuated the encephalitogenicity of transferred
cells in at-EAE. It is important to note that IL-17 producing CTL
[20] could not compensate for the loss in IL-17 producing Th cells
resulting from the depletion of the CCR6
+ Th cell fraction. The
ablation of CCR6
+ Th cells from lymph node cells of PLP
immunised mice almost completely prevented IL-17 production.
This experiment places emphasis on the correlation between IL-17
production and CCR6 expression. Interestingly, in vitro re-
stimulation of primed lymph node cells that were depleted for
CD4
+CCR6
+ cells, led to the emergence of CCR6
+ T cells but not
Th17 cells. As we were not able to completely block EAE
development by deletion of CCR6
+ Th17 cells, it is conceivable
that those cells regain functionality in vivo irrespective of their
inability to produce IL-17 during in vitro culture.
Up to now the generation of murine Th17 cells is accomplished
by polarizing these cells in vitro in the presence of cytokines such
as IL-6 and TGF-b [9,11]. Additionally, the spontaneous
development of CCR6
+ Th17 cells could be shown in autoim-
mune prone mice [27] but the stimulatory requirements for the
development of Th17 cells in the course of an infection are yet ill-
defined. In vitro IL-17 production can be forced by stimulating
lymph node cells with pathogenic components, such as LPS, CpG
DNA motifs, and pertussis toxin [9,28]. Those toll-like-receptor-
activating substances trigger the production of pro-inflammatory
cytokines by antigen presenting cells that further induce Th cell
differentiation towards the Th17 subtype. Thus, our non-
infectious vaccination scheme provides the opportunity to follow
the formation of Th17 cells in vivo.
In fact, we were able to induce antigen-specific Th17 cells by
our protocol. These cells were functional by producing IL-17
protein and expanding in response to their specific antigen without
the presence of additional polarizing cytokines. The presence of
IL-17 in antigen-specifically re-stimulated cell cultures suggested
the differentiation of Th17 cells from non-committed naı ¨ve T cells
after vaccination. However, since Th17 cells are most abundant in
naı ¨ve mice we cannot completely rule out whether that cytokine is
derived from pre-existing CCR6
+ memory cells. This implies the
presence of cross-reactive T cells within the IL-17 producing Th
cell subpopulation. Polyspecific T cells are part of the normal T
cell repertoire and initially selected against self- or microbial
antigens [29,30]. Although, the promiscuity in antigen recognition
is thought to be in particular important for T cell memory and
homeostasis it often leads to autoimmunity [31–34]. Indeed, IL-17
production in our experiments is accompanied with Th cells with a
memory phenotype. Since those cells are resistant to suppression
by regulatory T (Treg) cells [35] the occurrence of polyspecificity
within the Th17 cell subset might explain the detrimental role of
Th17 cells for the development of chronic inflammatory diseases.
Strikingly, our data demonstrate that Th1 cells became the
predominant Th cell subtype during the peak of the physiological
inflammatory response. As IFN-c negatively regulates IL-17
production in vitro [8] this cytokine also seems to display a
suppressive effect on Th17 cells in vaccinated mice. Since we
observed a reduction of Th17 cells under Th1, and Th2 polarizing
conditions these observations might reflect the differential
temporary needs for Th1 or Th2 cells and Th17 cells during the
course of an infection, and account for the different kinetics
underlying the development of these Th cell subtypes. Th17 cells
are equipped with homing receptors that allow them to reside in
peripheral tissues. We also noticed a robust proliferation and
expression of activation-induced receptors within the CCR6
+ Th
cell subset in non-vaccinated mice. This pointed to a Th cell
subpopulation that is constantly on the alert. Th cell-derived IL-17
induces the production of growth factors, cytokines, and
Figure 4. On day 21 after immunisation CD4
+ CCR6
+ prolifer-
ated in response to specific antigen. C57BL/6 mice were
immunised for 21 days. Lymph nodes cells of three mice were pooled
for each experiment and labelled with CFSE. (A) Cells were cultured for
96 h in the absence or presence of OVA. Proliferation was measured by
flow cytometry. The proportion of proliferating cells within the CD4
+
CCR6
+ fraction was determined. Each data point represents one
experiment (n=3/time point). Horizontal bars indicate the mean. *
p,0.05. (B) Cells were stimulated with anti-CD3 or OVA and
proliferation was assessed by flow cytometry. The percentage of
proliferating cells is depicted. One representative experiment out of
three is show.
doi:10.1371/journal.pone.0002951.g004
In Vivo Analysis of Th17 Cells
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stimulatory conditions creating the appropriate environment
needed for the recruitment of innate immune cells early in
inflammation [38,39]. Subsequently, during the peak of the
immune response Th1 cells assume their role in promoting the
functionality of CTL and macrophages.
An open question still remains: is ligation of CCR6 required for
in vivo activation of Th17 cells? Since blocking CNS-expressed
CCL20, the cognate ligand of CCR6, in active EAE results in an
attenuation of the disease [40,41] CCR6 expression seems to be
necessary for the generation of functional Th17 cells. Accordingly,
CCR6
2/2 mice exhibit impaired Th cell function in delayed type
Figure 5. Depletion of CD4
+ CCR6
+ T cells attenuates disease development in at-EAE. SJL/J mice were immunised as described in materials
and methods. On day 10 lymph nodes were harvested and cells were isolated. (A) Total lymph node cells (open bar) or lymph node cells depleted of
CD4
+ CCR6
+ cells (black bar) were cultured in vitro in the presence of PLP for 72 h. The production of IL-17 protein was quantified. ELISA was
performed in duplicates. Data represents the mean values (6SEM) of two independent experiments. * p,0.05. (B) Purified CD4
+ CCR6
+ (open bar) or
CD4
+ CCR6
2 (black bar) T cells were stimulated with plate bound anti-CD3 for 72 h. IL-17 was quantified. ELISA was performed in duplicates. Data
represents the mean values (6SEM) of three independent experiments. * p,0.05. (C) Mean EAE scores (6SEM) from mice received either total lymph
node cells (open squares) or CD4
+ CCR6
+ depleted lymph node cells (closed circles) are shown (n=5/group). The differences between the two groups
were statistically significant by day 6 through day 17. * p,0.05.
doi:10.1371/journal.pone.0002951.g005
Table 1. Depletion of CD4
+ CCR6
+ T cells attenuates disease in the at-EAE model.
Transferred cell type Incidence
a Mortality
a
Mean day of disease
onset Maximum score Cumulative score
b
Total LNC
c 5/5 3/5 6 (60; n=5) 4.5 (60.7; n=5) 46.7 (614.1; n=5)
CD4
+CCR6
+ depleted LNC
c 4/5 0/5 10 (64.6; n=5)
d 2.6 (61.6; n=5)
d 18.1 (613.9; n=5)
d
aClinical outcome of EAE of mice that had received either total lymph node cells or CD4
+CCR6
+ depleted lymph node cells is shown for the observation period of 20
days.
bCumulative score was calculated by summing up each individual score registered during the follow-up period.
cLNC, lymph node cells
dp,0.05 compared with control mice; Mann-Whitney U test.
doi:10.1371/journal.pone.0002951.t001
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ments [18,42]. These inflammatory conditions also test primed Th
cells for their functionality. One likely explanation is that in those
models the CCR6-mediated migration of Th cells into the target
organs is needed for a sufficient activation of Th17 cells. In
contrast, in the respective adoptive transfer EAE model blocking
CCL20 did not prevent the development of disease [40]. That
indicates once activated CCR6
+ Th17 cells remain functional.
They react against endogenous antigen and cause autoimmunity.
Together, these findings point to a defect in the differentiation
towards the Th17 subtype in the absence of CCR6.
From our observations, we conclude that CCR6
+ Th cells
represent an activated Th cell subpopulation. They are capable of
producing IL-17 after vaccination with protein antigens. However,
exceeded stimulation of Th17 cells results in a continuous
production of IL-17 that promotes autoimmune phenomena
[43]. Therefore, Th17 cells have to be controlled effectively.
CCR6 is a common attribute of certain tissue homing Treg cells
[44] and Th17 cells, and the dichotomy between Treg cells and
inflammation-promoting Th17 cells has been stated recently [11].
Equipped with a similar type of homing and activation receptors
both Th cell subtypes might meet at the sites of inflammation and
cross-regulate each other. Extending the knowledge of the
mechanisms influencing the generation and recruitment of Th17
cells in vivo, and the identification of additional target structures
on these cells may lead to new therapeutic approaches for the
treatment of autoimmune disorders or to the development of
innovative vaccination strategies.
Supporting Information
Figure S1 IL-17 production is down regulated during the
immune response. (A–C) C57BL/6 mice were immunised with
100 mg OVA either adsorbed to ImjectH alum (Pierce Biotech-
nology, Rockford, USA) or emulsified in incomplete Freund’s
adjuvant (IFA). Draining lymph nodes of naı ¨ve mice (black bar)
and mice immunised with Ova alum (grey bars) or IFA (open bars)
were harvested at the indicated time points. (A) Cells were
stimulated in vitro with plate bound anti-CD3 for 72 h. The
production of IL-17 protein was quantified. ELISA was performed
in duplicates. * p,0.05; compared to day 0. (B) Cells were applied
for intracellular cytokine staining immediately after isolation. The
percentage of IL-17 producing CCR6
+ cells (6SEM) within the
CD4
+ T cell fraction was determined by flow cytometry. * p,0.05;
compared to day 0. (C) Intracellular cytokine staining of lymph
node cells obtained on day 6 after immunisation was performed as
described in materials and methods. The percentage of IL-17
producing CCR6
+ cells within the CD4
+ T cell fraction was
determined by flow cytometry. Data represents the mean
values6SEM (n=3, control mice; n=4 immunised mice).
Found at: doi:10.1371/journal.pone.0002951.s001 (0.55 MB TIF)
Figure S2 CCR6 expression does not concur with IL-17
production in PLP re-stimulated lymph node cells. SJL/J mice
were immunised as described in materials and methods. (A) Total
lymph node cells (open bar) or lymph node cells depleted of CD4
+
CCR6
+ cells (black bar) were re-stimulated with PLP for 72 h in
vitro. The percentage of CCR6
+ cells within the CD4
+ T cell
fraction is shown. Data represents the mean values6SEM (n=4).
(B) After the 72 h re-stimulation period intracellular cytokine
staining was performed as described in materials and methods.
Cells were gated on CD4
+ CCR6
+ cells and the percentage of IL-
17 producing cells was calculated. Data is given as mean6SEM
(n=4; * p,0.05).
Found at: doi:10.1371/journal.pone.0002951.s002 (0.21 MB TIF)
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